Company: TELO
Filing Date: 2025-11-20
Form Type: PREM14A
Source: 0001493152-25-024463
Chunk: 107

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-11-20
Form: PREM14A
Chunk 107
---
--|:----|:-------|:--|:----|:--------|:--|:----|:------------------------------------------------|:--|:----|:-------|:--|:----|:--------|:--|:----|:---------------------------------------------------|:--|:----|:---------------------------------------------------------|----------:|---:|:----|:---------------------------------|-----:|---:|:----|:-----------------------------|-----:|:----|:------------------------------------------|----------:|
| Erez Aminov, CEO                |     |         | 8/27/2024 |     |                                                                 | - |     |        | - |     |         | - |     |                                                 | - |     |        | - |     |         | - |     |                                                    | - |     |                                                          | 1,960,170 | -2 |     | $                                | 5.02 | -4 |     | $                            | 5.26 |     | $                                         | 7,513,332 |
| Michelle Yanez, CFO             |     |         | 8/27/2024 |     |                                                                 | - |     |        |   |     |         | - |     |                                                 | - |     |        | - |     |         | - |     |                                                    | - |     |                                                          |   200,000 | -3 |     | $                                | 5.02 | -4 |     | $                            | 5.26 |     | $                                         |   782,000 |
| Christopher Chapman, former CEO |     |         | -         |     |                                                                 | - |     |        | - |     |         | - |     |                                                 | - |     |        | - |     |         | - |     |                                                    | - |     |                                                          |         - |    |     |                                  |    - |    |     |                              |    - |     |                                           |         - |
| Nathen Fuentes, former CFO      |     |         | -         |     |                                                                 | - |     |        | - |     |         | - |     |                                                 | - |     |        | - |     |         | - |     |                                                    | - |     |                                                          |         - |    |     |                                  |    - |    |     |                              |    - |     |                                           |         - |

(1) The “Grant Date